SEC Form 4 · accession 0001022079-17-000151
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon R Cohen
Officer — SVP & Group Exec. Diag. Sol.
Period of report
Jun 19, 2017
Accepted (ET)
Jun 21, 2017 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 19, 2017 | M | 13,680 | $57.605 | A | 86,863 | D | |
| Common Stock | Jun 19, 2017 | M | 29,340 | $56.12 | A | 116,203 | D | |
| Common Stock | Jun 19, 2017 | M | 63,880 | $52.165 | A | 180,083 | D | |
| Common StockF2 | Jun 19, 2017 | S | 13,344 | $107.52 | D | 166,739 | D | |
| Common StockF3 | Jun 19, 2017 | S | 336 | $108.149 | D | 166,403 | D | |
| Common StockF2 | Jun 19, 2017 | S | 28,182 | $107.527 | D | 138,221 | D | |
| Common StockF4 | Jun 19, 2017 | S | 1,158 | $108.137 | D | 137,063 | D | |
| Common StockF2 | Jun 19, 2017 | S | 61,321 | $107.529 | D | 75,742 | D | |
| Common StockF5 | Jun 19, 2017 | S | 2,559 | $108.134 | D | 73,183 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F6 | $57.605 | Jun 19, 2017 | M | 13,680 | D | — | Feb 27, 2022 | Common Stock | 13,680 | 0 | D |
| Stock Options (Right to Buy)F7 | $56.12 | Jun 19, 2017 | M | 29,340 | D | — | Feb 25, 2023 | Common Stock | 29,340 | 0 | D |
| Stock Options (Right to Buy)F8 | $52.165 | Jun 19, 2017 | M | 63,880 | D | — | Feb 13, 2024 | Common Stock | 63,880 | 0 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017.
- F2This transaction was executed in multiple trades at prices ranging from $107.12 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $108.14 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $108.12 to $108.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $108.12 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6The options vested in three annual installments beginning with the first on February 27, 2012, the second February 27, 2013 and the final on February 27, 2014.
- F7The options vested in three annual installments beginning with the first on February 25, 2013 the second on February 25, 2014 and the final on February 25, 2015.
- F8The options vested in three annual installments beginning with the first on February 13, 2014, the second on February 13, 2015 and the final on February 13, 2016.